SLC3A2 and cardiomyopathy, familial restrictive, 1: This is in contrast to recent findings that have confirmed these genes to be closely associated with RCM pathogenesis [5].Structural biology analyses demonstrated that the mutation is located in the β-myosin heavy chain rod tail structural domain, which plays a pivotal role in myocardial ganglion assembly and mechanical signalling.